Clinical overview of enfortumab vedotin in the management of locally advanced or metastatic urothelial carcinoma

KS Hanna - Drugs, 2020 - Springer
The treatment landscape for locally advanced or metastatic urothelial carcinoma has
broadened significantly over recent years. New therapeutic options include immunotherapy …
被引用次数：38 相关文章

Clinical Overview of Enfortumab Vedotin in the Management of Locally Advanced or Metastatic Urothelial Carcinoma

KS Hanna - Drugs, 2020 - pubmed.ncbi.nlm.nih.gov
The treatment landscape for locally advanced or metastatic urothelial carcinoma has
broadened significantly over recent years. New therapeutic options include immunotherapy …

Clinical Overview of Enfortumab Vedotin in the Management of Locally Advanced or Metastatic Urothelial Carcinoma.

KS Hanna - Drugs, 2020 - search.ebscohost.com
The treatment landscape for locally advanced or metastatic urothelial carcinoma has
broadened significantly over recent years. New therapeutic options include immunotherapy …

Clinical Overview of Enfortumab Vedotin in the Management of Locally Advanced or Metastatic Urothelial Carcinoma.

KS Hanna - Drugs, 2020 - europepmc.org
The treatment landscape for locally advanced or metastatic urothelial carcinoma has
broadened significantly over recent years. New therapeutic options include immunotherapy …

Clinical Overview of Enfortumab Vedotin in the Management of Locally Advanced or Metastatic Urothelial Carcinoma

KS Hanna - Drugs, 2020 - search.proquest.com
The treatment landscape for locally advanced or metastatic urothelial carcinoma has
broadened significantly over recent years. New therapeutic options include immunotherapy …